Manganese X
Subsidiary and JV Partner PureBiotic
Air Provide Virginia State University Results
on Biofilm
& Pathogens Including COVID -19
Montréal, Québec, Canada,
March
16th,
2021,
Manganese X Energy Corp. -- InvestorsHub NewsWire -- (TSXV:
MN) (FSE: 9SC2) ( (OTC:
MNXXF)
("Manganese X" ,
"MN" or
the "Company"
is pleased to
announce that its wholly owned subsidiary, Disruptive Battery Corp.
(DBC) in
conjunction with its US JV Partner, PureBiotic Air
Inc.(PureBiotic), has received positive preliminary results from
its ongoing research study with Virginia State University
(VSU). The
results include the successful production of
the biofilm required to advance its research and testing of the
PureBiotic HVAC Delivery System for the mitigation of COVID-19 and
other contaminants.
CEO
Martin Kepman stated
"The
Team is pleased with
the progress of the production of biofilm on various
type surfaces that
are found in all types of facilities and homes. This initial
step should
accelerate the required research and testing to document the ability of specific
PureBiotics AIR Mist Solutions to deconstruct and remove these
biofilm structures. It will create hostile environments
that will reduce the risk of pathogenic bacteria and viruses,
including the current pathogen of concern around the world,
SARS-CoV-2 virus that is causing the COVID-19 pandemic.
It
should also be noted that biofilm is calculated by the Centers for
Disease Control and Prevention (CDC) to be responsible for some 80%
of all infections and it is found on almost all surfaces, including
your skin. The company's ultimate goal is to create a product for
FDA certification."
STUDY SUMMARY: This
initial portion of the study covers the formation of biofilms on
different surface materials, specifically by pathogenic bacteria,
as per the protocols formulated by the VSU Research Team in
conjunction with JV Partner and
head of R&D at
PureBiotic, Lino G.
Morris. This will
meet the
specifications required to document the ability to grow the
mandatory required biofilm needed on a wide variety of test
surfaces.
The study will then further
document the ability of specific PureBiotics AIR Mist Solutions to
deconstruct and remove these biofilm structures down to the bare
microscopic level. This means the removal of any protective
cover creating hostile environments in order
to reduce the risk of pathogenic bacteria and viruses, including
the COVID-19 pathogen. Testing data on these
formulations for a wide range of Hospital Acquired
Infections (as well as in a wide variety of
both food production and food processing
facilities) has shown a major reduction in
overall infections when compared with standard hospital
disinfectants. There has also been an additional benefit in
the reduction of odours in all of the facilities
tested.
Various HVAC systems will also
be tested, as the final goal of these
studies, to determine whether
all biofilm
growth can
be removed. In addition to
the COVID-19
pathogens, there is
a large
range of bacterial, viral, mold and mildew
growths
and the significant
concern of allergens, all contained inside HVAC
systems.
It should be noted that
bacteria and viruses are commonly collected and especially found
growing in the cooling towers of buildings, and also contaminating
all of the various transportation sections/units of HVAC
systems (such as all the various ducts
works and air vents). There are additional
special problems in the cooling towers because of the affinity of
biofilm for binding of the minerals in the water used in all of
these systems for cooling. Further, eliminating biofilm from the coils of the
HVAC and associated systems will provide far healthier environments
and large savings in power consumption.
PRELIMINARY
RESULTS:
In previous tests, the results
indicated a significant ability of the PureBiotic AIR Solutions to
provide probable deconstruction of biofilm. This came from
the original indirect testing in which the PureBiotic AIR Solutions
were tested on contaminants in locations
such a hospital facility where many years of biofilm had built-up
on surfaces. When used and observed within a
time period of three weeks, there
were significant
test results in which the levels of pathogens were significantly
reduced on the floor and surrounding areas
of a hospital
facility regardless of
soiling, internal
spills and "accidents" that occurred. This
also
included testing
with a range of outside visitors walking the areas. The
regrowth of pathogens seriously declined and the areas treated were
visibly cleaner and grout lines had lightened, and by the end of the third
week, the testing for contamination showed dozens of clear plates
from all of the areas tested.
The initial conclusion, since
all testing to date has been positive, is that as the VSU study progresses, it
is anticipated that the results should continue to provide
additional proof of the benefits of this
breakthrough in controlling the microscopic
environment. It does so in a safe, easy, and low
labor methodology. More detailed results will be
provided as they are available.
The company is not making any
express or implied claim that it has developed a COVID-19 air
management solution at this time.
About Manganese X Energy Corp.
Manganese X's mission is to advance its Battery Hill project into
production, with the intent of supplying value-added materials to
the lithium-ion battery and other alternative energy industries,
The Company is also striving to achieve new carbon-friendly more
efficient methodologies, while processing manganese at a lower
competitive cost. The company is the only manganese company in
North America moving toward commercialization of
a manganese deposit.
Subsidiary Disruptive Battery Corp.'s mission is to develop an HVAC
(heating, ventilation and air conditioning) air purification
delivery system for cleaner and healthier air, aiming to mitigate
COVID-19 and other contaminants
on surfaces and in the air.
For more
information visit the website at
www.manganesexenergycorp.com
On behalf of
the Board of Directors of
MANGANESE X ENERGY CORP.
Martin
Kepman
CEO and
Director
Email: martin@kepman.com
Tel: 1-514-802-1814
Cautionary
Note Regarding Forward-Looking Statements:
Neither
TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of this
release.
This news
release contains "forward-looking information" including statements
with respect to the future exploration performance of the Company.
This forward-looking information involves known and unknown risks,
uncertainties and other factors which may cause the actual results,
performance or achievements of the Company to be materially
different from any future results, performance or achievements of
the Company, expressed or implied by such forward-looking
statements. These risks, as well as others, are disclosed within
the Company's filing on SEDAR, which investors are encouraged to
review prior to any transaction involving the securities of the
Company. Forward-looking information contained herein is provided
as of the date of this news release and the Company disclaims any
obligation, other than as required by law, to update any
forward-looking information for any reason. There can be no
assurance that forward-looking information will prove to be
accurate and the reader is cautioned not to place undue reliance on
such forward-looking information. We seek
safe harbor.
Manganese X Energy (TSXV:MN)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
Manganese X Energy (TSXV:MN)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024
